ClinicalTrials.govpublic full text
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms
relapsed or refractory plasma cell neoplasms, car-t, plasma cell neoplasms, cd19/bcma, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 967250
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.